"Cancer immune cell therapy" has been studied for more than 30 years, but the recognition as a promising cancer treatment method came out in the year 2011 when the first checkpoint inhibitor in the United States I think that it has been approved.

In Japan, long-term lymphocyte therapy is being done as a self-care treatment, but it is a presence that has been ignored, especially in the medical world of Japan where insurance medical treatment advanced.

From now on, however, the center of cancer therapy development is undoubtedly the cancer immunity cell treatment field. In Europe and the United States, we are paying attention to this field under the name of a new immun-onecology.

© Copyright 2017 CyTIX Inc. All rights reserved.